Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1342856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Adriana F Gonçalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Plasmodium falciparum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Introduction
Malaria parasites increasingly develop resistance to all drugs available in the market, hampering the goal of reducing malaria burden.
Methods
Herein, we evaluated the impact of a single-nucleotide variant, E738K, present in the 26S proteasome regulatory subunit rpn2 gene, identified in Plasmodium chabaudi resistant parasites. Plasmids carrying a functional rpn2 interspecies chimeric gene with 5’ recombination region from P. falciparum and 3’ from P. chabaudi were constructed and transfected into Dd2 P. falciparum parasites. Results and discussion The 738K variant parasite line presented increased parasite survival when subjected to dihydroartemisinin (DHA), as well as increased chymotrypsin-like activity and decreased accumulation of polyubiquitinated proteins. We thus conclude that the ubiquitin-proteasome pathway, including the 738K variant, play an important role in parasite response to DHA, being the first report of a mutation in a potential DHA drug target enhancing parasite survival and contributing to a significant advance in the understanding the biology of artemisinin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
- Life and Health Sciences Research Institute (ICVS)/ Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, Braga, Portugal.
- Department of Protection of Specific Crops, InnovPlantProtect Collaborative Laboratory, Elvas, Portugal.
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Lisbon,…
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Gonçalves, A. F., Lima-Pinheiro, A., Teixeira, M., Cassiano, G. C., Cravo, P., & Ferreira, P. E. (2024). Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1342856
Vancouver
Gonçalves AF, Lima-Pinheiro A, Teixeira M, Cassiano GC, Cravo P, Ferreira PE. Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1342856
BibTeX
@article{Gonalves2024,
author = {Gonçalves, Adriana F and Lima-Pinheiro, Ana and Teixeira, Miguel and Cassiano, Gustavo Capatti and Cravo, Pedro and Ferreira, Pedro E},
title = {Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1342856}
}
EUVIMED